(CBD, Synthetic)

CAS number: 13956-29-1

General information about the Cannabidiol active pharmaceutical ingredient

Cannabidiol as active pharmaceutical ingredient (API) is a sythetic version of the natural compound cannabidiol (CBD) found in the cannabis plant. Cannabidiol API is designed to mimic the chemical structure and properties of natural extract CBD. Cannabidiol API is used as anti-inflammatory and pain relief. Cannabidiol API is used to treat anxiety and depression, sleep problems and also skin conditions. Cannabidiol is used to treat seizures in people with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. Cannabidiol is available as oil, capsules, cream and ointment, spray and for vaporizers.

Axplora manufactures Cannabidiol API

Cannabidiol API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Cannabidiol API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Cannabidiol API is commercially available as standard grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Cannabidiol API.
  • Therapeutic area Various
  • Monograph DAC (German Drug Codex)
  • Available grade Standard
  • Regulatory documentation EU DMF
    US DMF
  • Produced in GRO